Cerity Partners’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,250
| Closed | -$28K | – | 1495 |
|
|
2022
Q3 | $28K | Hold |
1,250
| – | – | ﹤0.01% | 1157 |
|
|
2022
Q2 | $24K | Hold |
1,250
| – | – | ﹤0.01% | 1162 |
|
|
2022
Q1 | $58K | Hold |
1,250
| – | – | ﹤0.01% | 915 |
|
|
2021
Q4 | $89K | Hold |
1,250
| – | – | ﹤0.01% | 986 |
|
|
2021
Q3 | $146K | Sell |
1,250
-375
| -23% | -$43.8K | ﹤0.01% | 662 |
|
|
2021
Q2 | $254K | Hold |
1,625
| – | – | 0.01% | 631 |
|
|
2021
Q1 | $308K | Hold |
1,625
| – | – | 0.01% | 550 |
|
|
2020
Q4 | $204K | Hold |
1,625
| – | – | 0.01% | 594 |
|
|
2020
Q3 | $177K | Hold |
1,625
| – | – | 0.01% | 473 |
|
|
2020
Q2 | $195K | Hold |
1,625
| – | – | 0.01% | 425 |
|
|
2020
Q1 | $163K | Hold |
1,625
| – | – | 0.01% | 413 |
|
|
2019
Q4 | $394K | Buy |
+1,625
| New | +$394K | 0.02% | 378 |
|